Full text loading...
-
Cannabinoid Receptor Antagonists and the Metabolic Syndrome: Novel Promising Therapeutical Approaches
- Source: Mini Reviews in Medicinal Chemistry, Volume 7, Issue 1, Jan 2007, p. 21 - 30
-
- 01 Jan 2007
Abstract
Recent findings in animals and in humans have shown that cannabinoid type 1 receptor antagonists are suitable to become the most promising validated class of drugs to tackle obesity and related disorders. This mini-review will provide a concise and updated revision of the state of art on this topic.
© Bentham Science Publishers